Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FURESTEM-AD in Moderate to Severe Atopic Dermatitis
NCT01927705Phase 2Completed
- Sponsor
- Kangstem Biotech
- Start
- Sep 2013
- Primary completion
- May 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Promostem in atopic dermatitis (AD), sponsored by Kangstem Biotech. Started Sep 2013; status: completed.
02
Drugs
Promostem
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01927705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01927705.